Contact
Please use this form to send email to PR contact of this press release:
IBRX INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations Regarding FDA Complete Response Letter
TO: